Breast Cancer Screening Services: Trade-offs in Quality, Capacity, Outreach, and Centralization

[1]  Xuanming Su,et al.  Patient Choice in Kidney Allocation: A Sequential Stochastic Assignment Model , 2005, Oper. Res..

[2]  J. Caulkins,et al.  Dynamic drug policy: an introduction and overview , 2004 .

[3]  R Holland,et al.  Diagnostic accuracy for different strategies of image-guided breast intervention in cases of nonpalpable breast lesions , 2004, British Journal of Cancer.

[4]  A. Edwards,et al.  Women need better information about routine mammography , 2003, BMJ : British Medical Journal.

[5]  Joann G Elmore,et al.  Does practice make perfect when interpreting mammography? Part II. , 2003, Journal of the National Cancer Institute.

[6]  N. Urban,et al.  Analysis of the Cost-Effectiveness of Mammography Promotion by Volunteers in Rural Communities , 2002, Health education & behavior : the official publication of the Society for Public Health Education.

[7]  J. Elmore,et al.  Screening mammograms by community radiologists: variability in false-positive rates. , 2002, Journal of the National Cancer Institute.

[8]  D. Wolverton,et al.  Performance parameters for screening and diagnostic mammography: specialist and general radiologists. , 2002, Radiology.

[9]  Rebecca S Lewis,et al.  Does training in the Breast Imaging Reporting and Data System (BI-RADS) improve biopsy recommendations or feature analysis agreement with experienced breast imagers at mammography? , 2002, Radiology.

[10]  C. Lehman,et al.  Performance of diagnostic mammography for women with signs or symptoms of breast cancer. , 2002, Journal of the National Cancer Institute.

[11]  David L. Craft,et al.  Emergency response to a smallpox attack: The case for mass vaccination , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[12]  E. Conant,et al.  Factors affecting radiologist inconsistency in screening mammography. , 2002, Academic radiology.

[13]  J. Elmore,et al.  Does practice make perfect when interpreting mammography? , 2002, Journal of the National Cancer Institute.

[14]  Helen C. Cowley,et al.  Improving the accuracy of mammography: volume and outcome relationships. , 2002, Journal of the National Cancer Institute.

[15]  D. Haggstrom,et al.  All-cause mortality in randomized trials of cancer screening. , 2002, Journal of the National Cancer Institute.

[16]  Vedat Verter,et al.  Location of Preventive Health Care Facilities , 2002, Ann. Oper. Res..

[17]  E. Ellerbeck,et al.  Impact of Geographic Barriers on the Utilization of Mammograms by Older Rural Women , 2002, Journal of the American Geriatrics Society.

[18]  D. Gyrd-Hansen,et al.  Analysing public preferences for cancer screening programmes. , 2001, Health economics.

[19]  G. D'aiuto,et al.  An Assessment of Delays in Obtaining Definitive Breast Cancer Treatment in Southern Italy , 2001, Breast Cancer Research and Treatment.

[20]  S. Taplin,et al.  Quality assurance for screening mammography: an international comparison , 2001, Journal of epidemiology and community health.

[21]  J. Fischman New-style mammograms detect cancer. So do the old. Either way you wait. , 2001, U.S. news & world report.

[22]  A. Miller,et al.  Organized breast cancer screening programs in Canada. , 2000, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[23]  Prashant C. Fuloria,et al.  Managing the Delivery of Dialysis Therapy: A Multiclass Fluid Model Analysis , 2000 .

[24]  E A Sickles,et al.  Standardized abnormal interpretation and cancer detection ratios to assess reading volume and reader performance in a breast screening program. , 2000, Radiology.

[25]  H. Verkooijen,et al.  Diagnostic accuracy of large-core needle biopsy for nonpalpable breast disease: a meta-analysis , 2000, British Journal of Cancer.

[26]  E. Conant,et al.  How experience and training influence mammography expertise. , 1999, Academic radiology.

[27]  P. Littlejohns,et al.  Influence of delay on survival in patients with breast cancer: a systematic review , 1999, The Lancet.

[28]  P C Prorok,et al.  Estimation of post-lead-time survival under dependence between lead-time and post-lead-time survival. , 1999, Statistics in medicine.

[29]  P. Clarke,et al.  Cost-benefit analysis and mammographic screening: a travel cost approach. , 1998, Journal of health economics.

[30]  R. Baker,et al.  Use of a mathematical model to evaluate breast cancer screening policy , 1998, Health care management science.

[31]  H. D. de Koning,et al.  Cost effectiveness of shortening screening interval or extending age range of NHS breast screening programme: computer simulation study , 1998, BMJ.

[32]  M. Wallis,et al.  Slippage in the NHS breast screening programme: an assessment of whether a three year screening round is being achieved , 1998, Journal of medical screening.

[33]  K. Kerlikowske,et al.  Cost-Effectiveness of Extending Screening Mammography Guidelines To Include Women 40 to 49 Years of Age , 1997, Annals of Internal Medicine.

[34]  S. Shapiro,et al.  Reasons for delay in breast cancer diagnosis. , 1996, Preventive medicine.

[35]  S. Shapiro,et al.  System delay in breast cancer in whites and blacks. , 1995, American journal of epidemiology.

[36]  L. Tabár,et al.  Estimation of mean sojourn time in breast cancer screening using a Markov chain model of both entry to and exit from the preclinical detectable phase. , 1995, Statistics in medicine.

[37]  L. Green,et al.  The danger of applying uniform clinical policies across populations: the case of breast cancer in American Indians. , 1994, American journal of public health.

[38]  Marvin Zelen,et al.  Optimal scheduling of examinations for the early detection of disease , 1993 .

[39]  Süleyman Özekici,et al.  Optimal Scheduling of Inspections: A Delayed Markov Model with False Positives and Negatives , 1991, Oper. Res..

[40]  Hau L. Lee,et al.  Mass Screening Models for Contagious Diseases with No Latent Period , 1988, Oper. Res..

[41]  N. Day,et al.  Simplified models of screening for chronic disease: estimation procedures from mass screening programmes. , 1984, Biometrics.

[42]  S D Walter,et al.  Estimation of the duration of a pre-clinical disease state using screening data. , 1983, American journal of epidemiology.

[43]  Philip Heidelberger,et al.  Simulation Run Length Control in the Presence of an Initial Transient , 1983, Oper. Res..

[44]  William P. Pierskalla,et al.  Test selection for a mass screeening program , 1980 .

[45]  Michael Shwartz,et al.  A Mathematical Model Used to Analyze Breast Cancer Screening Strategies , 1978, Oper. Res..

[46]  Morton Klein,et al.  Surveillance Schedules for Medical Examinations , 1974 .

[47]  Justice Jw,et al.  CANCER SCREENING PROGRAM. , 1964 .

[48]  Stephen E. Chick,et al.  Microbial Risk Assessment for Drinking Water , 2005 .

[49]  C. Skinner,et al.  The cost effectiveness of 5 interventions to increase mammography adherence in a managed care population. , 2003, The American journal of managed care.

[50]  V. Chongsuvivatwong,et al.  Delay in breast cancer care: a study in Thai women. , 2000, Medical care.

[51]  C. Somkin,et al.  Cost of Care for Cancer in a Health Maintenance Organization , 1997, Health care financing review.

[52]  Averill M. Law,et al.  Simulation Modeling and Analysis , 1982 .